Mark Anthony Latina, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trabeculectomy | 18 | 2021 | 174 | 3.020 |
Why?
|
| Glaucoma, Open-Angle | 17 | 2021 | 739 | 1.820 |
Why?
|
| Laser Therapy | 22 | 2021 | 1094 | 1.770 |
Why?
|
| Intraocular Pressure | 31 | 2021 | 1295 | 1.390 |
Why?
|
| Trabecular Meshwork | 11 | 2009 | 101 | 1.310 |
Why?
|
| Glaucoma | 18 | 2012 | 1186 | 1.210 |
Why?
|
| Ocular Hypertension | 7 | 2021 | 209 | 0.840 |
Why?
|
| Sclera | 9 | 2011 | 190 | 0.710 |
Why?
|
| Glaucoma Drainage Implants | 3 | 2011 | 107 | 0.710 |
Why?
|
| Exfoliation Syndrome | 3 | 2011 | 113 | 0.620 |
Why?
|
| Sclerostomy | 4 | 2011 | 16 | 0.620 |
Why?
|
| Anterior Eye Segment | 2 | 2012 | 143 | 0.450 |
Why?
|
| Microscopy, Acoustic | 1 | 2012 | 47 | 0.410 |
Why?
|
| Iridocyclitis | 1 | 2011 | 11 | 0.390 |
Why?
|
| Cloprostenol | 1 | 2011 | 21 | 0.380 |
Why?
|
| Pericardium | 2 | 2011 | 674 | 0.380 |
Why?
|
| Glaucoma, Neovascular | 2 | 2009 | 37 | 0.340 |
Why?
|
| Optic Nerve Diseases | 2 | 2011 | 342 | 0.330 |
Why?
|
| Filtering Surgery | 2 | 2007 | 33 | 0.320 |
Why?
|
| Amides | 1 | 2011 | 449 | 0.310 |
Why?
|
| Lasers, Gas | 1 | 2009 | 101 | 0.290 |
Why?
|
| Blister | 1 | 2007 | 86 | 0.270 |
Why?
|
| Lasers, Solid-State | 1 | 2009 | 176 | 0.270 |
Why?
|
| Office Visits | 1 | 2009 | 594 | 0.230 |
Why?
|
| Eye | 5 | 2009 | 713 | 0.230 |
Why?
|
| Endophthalmitis | 1 | 2007 | 260 | 0.220 |
Why?
|
| Autoimmunity | 1 | 2011 | 1354 | 0.210 |
Why?
|
| Antihypertensive Agents | 2 | 2011 | 2019 | 0.200 |
Why?
|
| Prostheses and Implants | 5 | 1998 | 1276 | 0.200 |
Why?
|
| Tomography, Optical Coherence | 2 | 2012 | 2923 | 0.190 |
Why?
|
| Tonometry, Ocular | 4 | 2012 | 236 | 0.190 |
Why?
|
| Light Coagulation | 3 | 1992 | 72 | 0.190 |
Why?
|
| Glaucoma, Angle-Closure | 3 | 1992 | 191 | 0.190 |
Why?
|
| Conjunctiva | 6 | 2011 | 479 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2011 | 2981 | 0.180 |
Why?
|
| Phacoemulsification | 1 | 2002 | 150 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2003 | 354 | 0.170 |
Why?
|
| Interferon-gamma | 3 | 1993 | 3155 | 0.170 |
Why?
|
| Ophthalmic Solutions | 3 | 2011 | 312 | 0.160 |
Why?
|
| Eye Injuries | 1 | 2002 | 227 | 0.160 |
Why?
|
| Suture Techniques | 3 | 2011 | 768 | 0.150 |
Why?
|
| Fluoresceins | 2 | 1995 | 235 | 0.150 |
Why?
|
| Retinal Diseases | 3 | 2009 | 705 | 0.150 |
Why?
|
| Prosthesis Implantation | 2 | 2003 | 591 | 0.150 |
Why?
|
| Optics and Photonics | 2 | 2008 | 306 | 0.150 |
Why?
|
| Choroid Diseases | 1 | 1998 | 63 | 0.140 |
Why?
|
| Aqueous Humor | 2 | 1995 | 153 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2570 | 0.140 |
Why?
|
| Scleral Diseases | 1 | 1997 | 22 | 0.140 |
Why?
|
| Ciliary Body | 4 | 1992 | 168 | 0.140 |
Why?
|
| Iris | 3 | 2009 | 232 | 0.130 |
Why?
|
| Gonioscopy | 4 | 2005 | 155 | 0.130 |
Why?
|
| Orbital Neoplasms | 1 | 2017 | 222 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 1165 | 0.130 |
Why?
|
| Fistula | 1 | 1997 | 212 | 0.120 |
Why?
|
| Drainage | 2 | 1998 | 1158 | 0.120 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 422 | 0.110 |
Why?
|
| Phagocytosis | 3 | 2008 | 1525 | 0.100 |
Why?
|
| Laser Coagulation | 1 | 1995 | 330 | 0.100 |
Why?
|
| Postoperative Complications | 4 | 2007 | 15634 | 0.100 |
Why?
|
| Corneal Diseases | 1 | 1997 | 542 | 0.090 |
Why?
|
| Fascia | 1 | 1991 | 140 | 0.090 |
Why?
|
| Humans | 50 | 2021 | 761098 | 0.090 |
Why?
|
| Connective Tissue | 1 | 1992 | 419 | 0.090 |
Why?
|
| Hyperemia | 1 | 2011 | 225 | 0.090 |
Why?
|
| Optic Disk Drusen | 1 | 2009 | 38 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 1420 | 0.080 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 209 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2012 | 1818 | 0.070 |
Why?
|
| Accidents | 1 | 1988 | 165 | 0.070 |
Why?
|
| Lens, Crystalline | 2 | 1987 | 387 | 0.070 |
Why?
|
| Collagen | 2 | 1992 | 2635 | 0.070 |
Why?
|
| Reoperation | 4 | 2011 | 4304 | 0.070 |
Why?
|
| Crystallins | 1 | 1987 | 75 | 0.070 |
Why?
|
| Lasers | 3 | 2008 | 952 | 0.070 |
Why?
|
| Iontophoresis | 3 | 1992 | 74 | 0.070 |
Why?
|
| Drug Labeling | 1 | 1989 | 248 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1992 | 1162 | 0.060 |
Why?
|
| Immune System | 1 | 2011 | 792 | 0.060 |
Why?
|
| Rabbits | 5 | 1992 | 4749 | 0.060 |
Why?
|
| Retinal Ganglion Cells | 1 | 2011 | 810 | 0.060 |
Why?
|
| Cornea | 1 | 2012 | 1330 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2012 | 39121 | 0.060 |
Why?
|
| Fibroblasts | 2 | 1992 | 4137 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 1988 | 965 | 0.060 |
Why?
|
| Fluorescein | 2 | 1995 | 175 | 0.060 |
Why?
|
| Treatment Outcome | 8 | 2021 | 64670 | 0.060 |
Why?
|
| Hyperpigmentation | 1 | 2005 | 116 | 0.060 |
Why?
|
| Retinal Neoplasms | 1 | 2005 | 148 | 0.050 |
Why?
|
| Aged | 17 | 2012 | 169266 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 4849 | 0.050 |
Why?
|
| Retinoblastoma | 1 | 2005 | 319 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 743 | 0.050 |
Why?
|
| Aged, 80 and over | 8 | 2011 | 58946 | 0.050 |
Why?
|
| Middle Aged | 17 | 2017 | 220835 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 12975 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2007 | 2643 | 0.040 |
Why?
|
| Fibrosis | 1 | 2007 | 2051 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1160 | 0.040 |
Why?
|
| Cataract | 4 | 2002 | 832 | 0.040 |
Why?
|
| Ischemia | 1 | 2009 | 1889 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3114 | 0.040 |
Why?
|
| Melanins | 2 | 2008 | 289 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2012 | 80673 | 0.040 |
Why?
|
| Female | 20 | 2017 | 392458 | 0.040 |
Why?
|
| Methylene Blue | 2 | 1990 | 155 | 0.040 |
Why?
|
| Male | 18 | 2012 | 360675 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2635 | 0.040 |
Why?
|
| Timolol | 1 | 1998 | 51 | 0.040 |
Why?
|
| Pilocarpine | 1 | 1998 | 64 | 0.040 |
Why?
|
| Visual Acuity | 6 | 2004 | 2677 | 0.040 |
Why?
|
| Cells, Cultured | 5 | 2008 | 18926 | 0.040 |
Why?
|
| Cell Survival | 3 | 2008 | 5776 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2003 | 2115 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1998 | 2562 | 0.030 |
Why?
|
| Argon | 2 | 2004 | 36 | 0.030 |
Why?
|
| Anterior Chamber | 2 | 1992 | 194 | 0.030 |
Why?
|
| Safety | 1 | 1998 | 1151 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1993 | 110 | 0.030 |
Why?
|
| Connective Tissue Cells | 1 | 1992 | 49 | 0.030 |
Why?
|
| Animals | 11 | 2009 | 168083 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 6507 | 0.030 |
Why?
|
| Eye Diseases | 2 | 1990 | 653 | 0.030 |
Why?
|
| Pilot Projects | 2 | 1998 | 8639 | 0.030 |
Why?
|
| Surgical Flaps | 2 | 1992 | 1670 | 0.020 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1990 | 68 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 75 | 0.020 |
Why?
|
| Ocular Hypotension | 1 | 1990 | 23 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1988 | 10203 | 0.020 |
Why?
|
| Microspheres | 1 | 1993 | 783 | 0.020 |
Why?
|
| Visual Fields | 2 | 2009 | 1059 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 39953 | 0.020 |
Why?
|
| Neodymium | 1 | 1989 | 19 | 0.020 |
Why?
|
| Ligation | 1 | 1990 | 446 | 0.020 |
Why?
|
| Prognosis | 2 | 2009 | 29672 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 1990 | 123 | 0.020 |
Why?
|
| Drug Packaging | 1 | 1988 | 43 | 0.020 |
Why?
|
| Injections | 1 | 1992 | 832 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14023 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 21357 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1993 | 1169 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2008 | 292 | 0.020 |
Why?
|
| Atrophy | 2 | 1992 | 1633 | 0.020 |
Why?
|
| Risk Factors | 2 | 2007 | 74219 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 1988 | 190 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2253 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1991 | 2468 | 0.020 |
Why?
|
| Strabismus | 1 | 1991 | 317 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 1990 | 445 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4908 | 0.020 |
Why?
|
| Visual Field Tests | 1 | 2009 | 410 | 0.020 |
Why?
|
| Corneal Stroma | 1 | 1988 | 171 | 0.020 |
Why?
|
| Ultrasonography | 2 | 1998 | 5971 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1990 | 319 | 0.020 |
Why?
|
| Biotechnology | 1 | 2008 | 281 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1988 | 606 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 1988 | 290 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2007 | 1159 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2637 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6781 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1987 | 658 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 1991 | 1334 | 0.020 |
Why?
|
| Vision Disorders | 2 | 2009 | 1088 | 0.020 |
Why?
|
| Actins | 1 | 1993 | 2046 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 1988 | 901 | 0.020 |
Why?
|
| Eye Enucleation | 1 | 2005 | 128 | 0.020 |
Why?
|
| Kinetics | 1 | 1993 | 6312 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 1988 | 539 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 1987 | 490 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 1987 | 449 | 0.010 |
Why?
|
| Surface Properties | 1 | 2007 | 1162 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1988 | 1703 | 0.010 |
Why?
|
| Prevalence | 1 | 2002 | 15717 | 0.010 |
Why?
|
| Necrosis | 1 | 1989 | 1611 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 10755 | 0.010 |
Why?
|
| Cell Division | 1 | 1991 | 4451 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1993 | 5870 | 0.010 |
Why?
|
| Medication Errors | 1 | 1989 | 783 | 0.010 |
Why?
|
| Apoptosis | 1 | 1998 | 9478 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6585 | 0.010 |
Why?
|
| Adult | 9 | 2005 | 221083 | 0.010 |
Why?
|
| Light | 1 | 1987 | 1351 | 0.010 |
Why?
|
| Wound Healing | 1 | 1991 | 2801 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3509 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2008 | 3665 | 0.010 |
Why?
|
| Nurses | 1 | 1988 | 2476 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1992 | 12341 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 9317 | 0.010 |
Why?
|
| Retina | 1 | 2008 | 2656 | 0.010 |
Why?
|
| Mitomycin | 1 | 1998 | 263 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1986 | 3770 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1998 | 54419 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1988 | 4538 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4060 | 0.010 |
Why?
|
| Life Tables | 1 | 1995 | 364 | 0.010 |
Why?
|
| Epinephrine | 1 | 1998 | 792 | 0.010 |
Why?
|
| Adolescent | 5 | 1995 | 88271 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1998 | 1081 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1998 | 1642 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3416 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1992 | 18217 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 3819 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 9001 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9455 | 0.010 |
Why?
|
| Uveitis, Anterior | 1 | 1992 | 101 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 23713 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 9185 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1998 | 1945 | 0.010 |
Why?
|
| Dialysis | 1 | 1990 | 73 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 36418 | 0.010 |
Why?
|
| Infant | 2 | 2005 | 36164 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 2171 | 0.000 |
Why?
|
| Aging | 1 | 1987 | 8701 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1990 | 1761 | 0.000 |
Why?
|
| Dinoprostone | 1 | 1990 | 597 | 0.000 |
Why?
|
| Interleukin-1 | 1 | 1990 | 1250 | 0.000 |
Why?
|
| Child, Preschool | 3 | 1995 | 42217 | 0.000 |
Why?
|
| Retinal Detachment | 1 | 1990 | 429 | 0.000 |
Why?
|
| Choroid Neoplasms | 1 | 1986 | 177 | 0.000 |
Why?
|
| Eyelid Neoplasms | 1 | 1986 | 89 | 0.000 |
Why?
|
| Eye Neoplasms | 1 | 1986 | 307 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1990 | 2359 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1990 | 1434 | 0.000 |
Why?
|
| Syndrome | 1 | 1990 | 3269 | 0.000 |
Why?
|
| Child | 4 | 1995 | 80134 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1990 | 1891 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 20600 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1990 | 1738 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1990 | 5478 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1990 | 8000 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1986 | 4021 | 0.000 |
Why?
|
| Inflammation | 1 | 1990 | 10758 | 0.000 |
Why?
|
| Melanoma | 1 | 1986 | 5694 | 0.000 |
Why?
|
| Mice | 1 | 1990 | 81324 | 0.000 |
Why?
|